Alkermes Investigational Site

Gatineau, Quebec J8Y 1W2

0 studies enrolling now · 3 studies all time

What they study most

Major Depressive Disorder, Multiple Sclerosis

Studies at this site

• A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1 — Completed
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study — Completed
• A Long-Term Safety Study of ALKS 5461 — Completed